GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DocCheck AG (XTER:AJ91) » Definitions » EBITDA per Share

DocCheck AG (XTER:AJ91) EBITDA per Share : €2.32 (TTM As of Jun. 2023)


View and export this data going back to 2000. Start your Free Trial

What is DocCheck AG EBITDA per Share?

DocCheck AG's EBITDA per Share for the six months ended in Jun. 2023 was €0.81. Its EBITDA per Share for the trailing twelve months (TTM) ended in Jun. 2023 was €2.32.

During the past 12 months, the average EBITDA per Share Growth Rate of DocCheck AG was -18.30% per year. During the past 3 years, the average EBITDA per Share Growth Rate was 26.60% per year. During the past 5 years, the average EBITDA per Share Growth Rate was 35.30% per year. During the past 10 years, the average EBITDA per Share Growth Rate was 21.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per Share growth rate using EBITDA per Share data.

The historical rank and industry rank for DocCheck AG's EBITDA per Share or its related term are showing as below:

XTER:AJ91' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -5.5   Med: 12   Max: 62
Current: 26.6

During the past 13 years, the highest 3-Year average EBITDA per Share Growth Rate of DocCheck AG was 62.00% per year. The lowest was -5.50% per year. And the median was 12.00% per year.

XTER:AJ91's 3-Year EBITDA Growth Rate is ranked better than
68.85% of 520 companies
in the Healthcare Providers & Services industry
Industry Median: 12.05 vs XTER:AJ91: 26.60

DocCheck AG's EBITDA for the six months ended in Jun. 2023 was €4.12 Mil.

During the past 12 months, the average EBITDA Growth Rate of DocCheck AG was -18.40% per year. During the past 3 years, the average EBITDA Growth Rate was 26.90% per year. During the past 5 years, the average EBITDA Growth Rate was 35.50% per year. During the past 10 years, the average EBITDA Growth Rate was 22.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 13 years, the highest 3-Year average EBITDA Growth Rate of DocCheck AG was 62.50% per year. The lowest was -8.10% per year. And the median was 12.10% per year.


DocCheck AG EBITDA per Share Historical Data

The historical data trend for DocCheck AG's EBITDA per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DocCheck AG EBITDA per Share Chart

DocCheck AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EBITDA per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.93 1.31 3.15 3.97 2.65

DocCheck AG Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
EBITDA per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.28 1.68 1.15 1.50 0.81

DocCheck AG EBITDA per Share Calculation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

DocCheck AG's EBITDA per Share for the fiscal year that ended in Dec. 2022 is calculated as

EBITDA per Share(A: Dec. 2022 )
=EBITDA/Shares Outstanding (Diluted Average)
=13.422/5.061
=2.65

DocCheck AG's EBITDA per Share for the quarter that ended in Jun. 2023 is calculated as

EBITDA per Share(Q: Jun. 2023 )
=EBITDA/Shares Outstanding (Diluted Average)
=4.124/5.064
=0.81

EBITDA per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €2.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DocCheck AG  (XTER:AJ91) EBITDA per Share Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals EBIT. EBIT is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost, it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies.


DocCheck AG EBITDA per Share Related Terms

Thank you for viewing the detailed overview of DocCheck AG's EBITDA per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


DocCheck AG (XTER:AJ91) Business Description

Traded in Other Exchanges
Address
Doccheck AG, Vogelsanger Strac E 66, Koln, DEU, 50823
DocCheck AG is a Germany-based company engaged in the healthcare sector. It operates through subsidiaries: antwerpes AG develops integrated communication concepts for the healthcare sector, including social media and digital communication with focus on e-marketing concepts, search engine optimization (SEO), search engine advertising (SEA) and search engine marketing (SEM); DocCheck Medical Services GmbH operates an online platform for healthcare professionals, such as physicians and pharmacists; DocCheck Medizinbedarf und Logistik GmbH wholesales medical products from third parties and also produces own medical products, and DocCheck Guano AG is a venture capital company with focus on e-health companies and promotes healthcare startups.
Executives
Dr. Frank Antwerpes Board of Directors

DocCheck AG (XTER:AJ91) Headlines

No Headlines